Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy - Results of a United Kingdom phase II trial (CNS 2007 04)

European Journal of Cancer

Volumn 49, Issue 18, 2013, Pages 3856-3862

  Bailey, S ^a   Howman, A ^b   Wheatley, K ^b   Wherton, D ^b   Boota, N ^c   Pizer, B ^d   Fisher, D ^e   Kearns, P ^b   Picton, S ^f   Saran, F ^g   Gibson, M ^b   Glaser, A ^f   Connolly, D J A ^h   Hargrave, D ⁱ  

^a Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Nottingham Clinical Trials Unit   (United Kingdom)

^d ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^e Department of Paediatrics   (United Kingdom)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

ⁱ GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Diffuse intrinsic pontine glioma (DIPG); Temozolomide

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

ABDOMINAL DISEASE; ADJUVANT CHEMORADIOTHERAPY; ADOLESCENT; ADULT; ARTICLE; ATAXIA; CANCER RESISTANCE; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CRANIAL NEUROPATHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INDUCTION CHEMOTHERAPY; INFECTION; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; LYMPHOCYTOPENIA; MAINTENANCE CHEMOTHERAPY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PONTINE GLIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; SCHOOL CHILD; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA; UNITED KINGDOM; VOMITING;

DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG); TEMOZOLOMIDE;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN STEM NEOPLASMS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DACARBAZINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; GREAT BRITAIN; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; QUALITY OF LIFE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888016199     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.08.006     Document Type: Article

References (39)

1. D. Hargrave, U. Bartels, and E. Bouffet Diffuse brainstem glioma in children: critical review of clinical trials Lancet Oncol 7 2006 241 248
2. I. Qaddoumi, I. Sultan, and A. Gajjar Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database Cancer 115 2009 5761 5770
3. M.H. Jansen, D.G. van Vuurden, W.P. Vandertop, and G.J. Kaspers Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology Cancer Treat Rev 38 2012 27 35
4. C.R. Freeman, and S. Suissa Brain stem tumors in children: results of a survey of 62 patients treated with radiotherapy Int J Radiat Oncol Biol Phys 12 1986 1823 1828
5. C.R. Freeman, J.P. Krischer, and R.A. Sanford Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study Int J Radiat Oncol Biol Phys 27 1993 197 206
6. C.S. Kretschmar, N.J. Tarbell, P.D. Barnes, J.P. Krischer, P.C. Burger, and L. Kun Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833 Cancer 72 1993 1404 1413
7. J. Lewis, H. Lucraft, and A. Gholkar UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group Int J Radiat Oncol Biol Phys 38 1997 925 929
8. R.J. Packer, J.M. Boyett, and R.A. Zimmerman Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial Cancer 72 1993 1414 1421
9. F. Doz, S. Neuenschwander, and E. Bouffet Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d'Oncologie Pediatrique Eur J Cancer 38 2002 815 819
10. M.T. Jennings, R. Sposto, and J.M. Boyett Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group J Clin Oncol 20 2002 3431 3437
11. R.J. Packer, M. Krailo, and M. Mehta A phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas Cancer 104 2005 1968 1974
12. A.W. Walter, A. Gajjar, and J.S. Ochs Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study Med Pediatr Oncol 30 1998 28 33
13. D.N. Korones, P.G. Fisher, and C. Kretschmar Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study Pediatr Blood Cancer 50 2008 227 230
14. E. Bouffet, M. Raquin, and F. Doz Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas Cancer 88 2000 685 692
15. A. Broniscer, C.C. Leite, V.L. Lanchote, T.M. Machado, and L.M. Cristofani Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group J Clin Oncol 18 2000 1246 1253
16. A. Sabharwal, R. Waters, and S. Danson Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells Melanoma Res 20 6 2011 502 508
17. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
18. A. Chassot, S. Canale, and P. Varlet Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma J Neurooncol 106 2012 399 407
19. K.J. Cohen, R.L. Heideman, and T. Zhou Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group Neuro Oncol 13 2011 410 416
20. R. Jalali, N. Raut, and B. Arora Prospective Evaluation of Radiotherapy With Concurrent and Adjuvant Temozolomide in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma Int J Radiat Oncol Biol Phys 77 2010 113 118
21. J.R. Sharp, E. Bouffet, and D. Stempak A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma Eur J Cancer 46 2010 3271 3279
22. A.W. Tolcher, S.L. Gerson, and L. Denis Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules Br J Cancer 88 2003 1004 1011
23. M.E. Hegi, L. Liu, and J.G. Herman Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity J Clin Oncol 26 2008 4189 4199
24. S. Baruchel, M. Diezi, and D. Hargrave Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours Eur J Cancer 42 2006 2335 2342
25. W.J. Furlong, D.H. Feeny, G.W. Torrance, and R.D. Barr The health utilities index (HUI) system for assessing health-related quality of life in clinical studies Ann Med 33 2001 375 384
26. R. Goodman The strengths and difficulties questionnaire: a research note J Child Psychol Psychiatry 38 1997 581 586
27. L.D. Case, and T.M. Morgan Design of phase II cancer trials evaluating survival probabilities BMC Med Res Methodol 3 2003 6
28. A. Broniscer, F.H. Laningham, R.P. Sanders, L.E. Kun, D.W. Ellison, and A. Gajjar Young age may predict a better outcome for children with diffuse pontine glioma Cancer 113 2008 566 572
29. J. Dunn, A. Baborie, and F. Alam Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy Br J Cancer 101 2009 124 131
30. A.A. Brandes, E. Franceschi, and A. Tosoni Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status Cancer 27 8 2009 1275 1279
31. M. Brada, S. Stenning, and R. Gabe Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma J Clin Oncol 28 2010 4601 4608
32. M. Zarghooni, U. Bartels, and E. Lee Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets J Clin Oncol 28 2010 1337 1344
33. N.U. Barua, S.P. Lowis, M. Woolley, S. O'Sullivan, R. Harrison, and S.S. Gill Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma 2013 Acta Neurochir Wien
34. R.C. Anderson, B. Kennedy, and C.L. Yanes Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children J Neurosurg Pediatr 11 2013 289 295
35. D. Hargrave Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism? CNS Oncol 1 2012 137 1148
36. B.S. Paugh, A. Broniscer, and C. Qu Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma J Clin Oncol 29 2011 3999 4006
37. G. Wu, A. Broniscer, and T.A. McEachron Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas Nat Genet 44 2012 251 253
38. D.A. Khuong-Quang, P. Buczkowicz, and P. Rakopoulos K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas Acta Neuropathol 124 2012 439 447
39. J. Schwartzentruber, A. Korshunov, and X.Y. Liu Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma Nature 482 2012 226 231